JP Morgan Chase’s Merck MRK Stock Holding History

JP Morgan Chase’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.68B	Sell	43,886,420 -9,086,563	-17%	-$1.06B	0.31%	65
2026 Q1	$6.26B	Buy	52,972,983 +23,773,005	+81%	+$2.74B	0.4%	43
2025 Q4	$3.07B	Sell	29,199,978 -6,001,669	-17%	-$563M	0.19%	112
2025 Q3	$2.95B	Buy	35,201,647 +3,379,875	+11%	+$278M	0.18%	121
2025 Q2	$2.52B	Buy	31,821,772 +3,313,550	+12%	+$263M	0.16%	132
2025 Q1	$2.56B	Buy	28,508,222 +1,398,367	+5%	+$131M	0.19%	121
2024 Q4	$2.7B	Sell	27,109,855 -176,010	-0.6%	-$18.1M	0.2%	109
2024 Q3	$3.1B	Sell	27,285,865 -801,113	-3%	-$95.2M	0.24%	97
2024 Q2	$3.48B	Buy	28,086,978 +1,426,061	+5%	+$184M	0.29%	73
2024 Q1	$3.52B	Buy	26,660,917 +764,399	+3%	+$94.2M	0.3%	73
2023 Q4	$2.82B	Buy	25,896,518 +2,942,711	+13%	+$305M	0.27%	86
2023 Q3	$2.36B	Sell	22,953,807 -1,109,509	-5%	-$120M	0.26%	89
2023 Q2	$2.78B	Buy	24,063,316 +4,350,744	+22%	+$494M	0.3%	78
2023 Q1	$2.1B	Sell	19,712,572 -4,082,769	-17%	-$441M	0.26%	93
2022 Q4	$2.64B	Buy	23,795,341 +305,417	+1%	+$31.2M	0.35%	66
2022 Q3	$2.02B	Buy	23,489,924 +760,074	+3%	+$67.9M	0.29%	82
2022 Q2	$2.07B	Buy	22,729,850 +3,668,227	+19%	+$325M	0.29%	82
2022 Q1	$1.56B	Buy	19,061,623 +881,291	+5%	+$69.5M	0.19%	123
2021 Q4	$1.39B	Buy	18,180,332 +911,398	+5%	+$72.6M	0.16%	142
2021 Q3	$1.3B	Sell	17,268,934 -3,718,145	-18%	-$283M	0.16%	144
2021 Q2	$1.63B	Sell	20,987,079 -5,357,766	-20%	-$399M	0.19%	122
2021 Q1	$1.94B	Sell	26,344,845 -1,039,350	-4%	-$76.7M	0.26%	86
2020 Q4	$2.14B	Sell	27,384,195 -2,426,320	-8%	-$186M	0.31%	66
2020 Q3	$2.33B	Buy	29,810,515 +1,230,690	+4%	+$96.4M	0.39%	51
2020 Q2	$2.11B	Sell	28,579,825 -3,826,829	-12%	-$288M	0.41%	47
2020 Q1	$2.38B	Sell	32,406,654 -3,933,012	-11%	-$309M	0.56%	31
2019 Q4	$3.15B	Sell	36,339,666 -2,322,841	-6%	-$191M	0.59%	29
2019 Q3	$3.11B	Sell	38,662,507 -3,751,158	-9%	-$301M	0.62%	23
2019 Q2	$3.39B	Sell	42,413,665 -11,925,078	-22%	-$913M	0.66%	21
2019 Q1	$4.31B	Buy	54,338,743 +7,989,170	+17%	+$598M	0.88%	8
2018 Q4	$3.38B	Buy	46,349,573 +262,676	+0.6%	+$18.5M	0.78%	10
2018 Q3	$3.12B	Sell	46,086,897 -1,019,296	-2%	-$64.9M	0.6%	17
2018 Q2	$2.73B	Buy	47,106,193 +7,214,119	+18%	+$407M	0.56%	25
2018 Q1	$2.07B	Buy	39,892,074 +4,805,374	+14%	+$260M	0.44%	32
2017 Q4	$1.88B	Buy	35,086,700 +600,833	+2%	+$33.3M	0.4%	38
2017 Q3	$2.12B	Sell	34,485,867 -2,434,632	-7%	-$148M	0.47%	29
2017 Q2	$2.26B	Sell	36,920,499 -769,176	-2%	-$46.8M	0.52%	25
2017 Q1	$2.29B	Buy	37,689,675 +5,411	+0%	+$328K	0.52%	26
2016 Q4	$2.12B	Buy	37,684,264 +4,406,463	+13%	+$258M	0.51%	25
2016 Q3	$1.98B	Buy	33,277,801 +5,731,657	+21%	+$335M	0.49%	29
2016 Q2	$1.51B	Buy	27,546,144 +3,651,391	+15%	+$194M	0.38%	45
2016 Q1	$1.21B	Sell	23,894,753 -2,393,936	-9%	-$117M	0.31%	62
2015 Q4	$1.32B	Sell	26,288,689 -3,817,227	-13%	-$192M	0.33%	54
2015 Q3	$1.42B	Sell	30,105,916 -15,750,699	-34%	-$837M	0.38%	50
2015 Q2	$2.49B	Sell	45,856,615 -238,081	-0.5%	-$13.4M	0.59%	26
2015 Q1	$2.53B	Sell	46,094,696 -3,115,514	-6%	-$176M	0.58%	23
2014 Q4	$2.67B	Buy	49,210,210 +3,516,273	+8%	+$196M	0.61%	19
2014 Q3	$2.58B	Buy	45,693,937 +7,731,329	+20%	+$434M	0.61%	20
2014 Q2	$2.1B	Sell	37,962,608 -5,174,226	-12%	-$282M	0.53%	28
2014 Q1	$2.34B	Buy	43,136,834 +8,209,999	+24%	+$425M	0.64%	19
2013 Q4	$1.67B	Sell	34,926,835 -1,749,014	-5%	-$79.9M	0.47%	37
2013 Q3	$1.67B	Sell	36,675,849 -2,715,728	-7%	-$124M	0.49%	31
2013 Q2	$1.75B	Buy	+39,391,577	New	+$1.76B	0.56%	26

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

JP Morgan Chase's MRK Position: Q2 2026 in Review

JP Morgan Chase reduced its Merck (MRK) stake by 17% in Q2 2026, selling an estimated $1.06B and leaving 43,886,420 shares worth $5.68B. The position accounts for 0.31% of the portfolio, ranked #65.

JP Morgan Chase first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.26B in Q1 2026. 3,813 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

JP Morgan Chase held 43,886,420 shares of Merck worth $5.68B as of Q2 2026.
JP Morgan Chase sold 9,086,563 Merck shares in Q2 2026, an estimated $1.06B.
Merck made up 0.31% of JP Morgan Chase's portfolio in Q2 2026, its #65 holding.
JP Morgan Chase first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
JP Morgan Chase's Merck position peaked at $6.26B in Q1 2026.
3,813 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.